repirinast has been researched along with Urticaria in 1 studies
repirinast: structure given in first source
Urticaria: A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.
Excerpt | Relevance | Reference |
---|---|---|
"We describe the first case of drug-induced solar urticaria due to repirinast, an antiallergic drug developed and introduced into the market in Japan in 1987." | 7.69 | Drug-induced solar urticaria due to repirinast. ( Kurumaji, Y; Shono, M, 1994) |
"We describe the first case of drug-induced solar urticaria due to repirinast, an antiallergic drug developed and introduced into the market in Japan in 1987." | 3.69 | Drug-induced solar urticaria due to repirinast. ( Kurumaji, Y; Shono, M, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kurumaji, Y | 1 |
Shono, M | 1 |
1 other study available for repirinast and Urticaria
Article | Year |
---|---|
Drug-induced solar urticaria due to repirinast.
Topics: Aged; Dermatitis, Photoallergic; Female; Histamine Antagonists; Humans; Quinolones; Sunlight; Ultrav | 1994 |